Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Understanding and Treating Suicidal Ideation With Ketamine: A Diffusion Magnetic Resonance Imaging Study

NCT06891300 is registered in ClinicalTrials.gov with The Royal's Institute of Mental Health Research as lead sponsor.

NCT NCT06891300
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06891300 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Understanding and Treating Suicidal Ideation With Ketamine: A Diffusion Magnetic Resonance Imaging Study
Lead sponsor
The Royal's Institute of Mental Health Research
Phase
Phase 2/3
Overall status
Recruiting
Start date
April 8, 2025
Completion date
October 31, 2026
Enrollment
36 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

major depressive disorder (mdd), suicidal ideation